Received Apr 15, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| DTAP | DTAP (INFANRIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | 9KB9G | — |
12-year-old patient was administered Infanrix; This non-serious case was reported by a nurse via call center representative and described the occurrence of inappropriate age at vaccine administration in a 12-year-old female patient who received DTPa (Infanrix) (batch number 9KB9G) for prophylaxis. On 10-MAR-2025, the patient received Infanrix. On 10-MAR-2025, an unknown time after receiving Infanrix, the patient experienced inappropriate age at vaccine administration (Verbatim: 12-year-old patient was administered Infanrix). The outcome of the inappropriate age at vaccine administration was not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 08-APR-2025 Nurse stated that a 12-year-old patient was administered Infanrix, which led to inappropriate age at vaccine administration. The reporter consented to follow up. The Vaccine Administration Facility is the same as Primary Reporter. Healthcare professional did not have expiration date at the time of the call.